Let’s Talk Ophthalmology: an Evolve Medical Education Podcast en © 2023 Evolve Medical Education LLC. All Rights Reserved. This podcast features content for the modern ophthalmologists, including topics such as cataract and refractive surgery, glaucoma, and retinal disease, among others. Evolve’s podcasts help today's ophthalmologists stay current on important topics in an easy-to-access, on-demand format. https://megaphone.imgix.net/podcasts/69d2cf0e-4de4-11ee-ad9e-439313fdf0aa/image/Lets_Talk_Ophthalmology_Podcast_Cover_Image.v2.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress Let’s Talk Ophthalmology: an Evolve Medical Education Podcast no episodic Evolve Medical Education, LLC This podcast features content for the modern ophthalmologists, including topics such as cataract and refractive surgery, glaucoma, and retinal disease, among others. Evolve’s podcasts help today's ophthalmologists stay current on important topics in an easy-to-access, on-demand format. This podcast features content for the modern ophthalmologists, including topics such as cataract and refractive surgery, glaucoma, and retinal disease, among others. Evolve’s podcasts help today's ophthalmologists stay current on important topics in an easy-to-access, on-demand format.

]]> Evolve Medical Education, LLC stephanie@evolvemeded.com Adapting to Progress: Vorolanib Intravitreal Implant https://evolvemeded.com/specialty/general-ophthalmology/2413-adapting-to-progress-vorolanib-intravitreal-implant/30045/?utm_source=megaphone&utm_medium=ophthalmology_episode_description The pipeline for the treatment of wet age-related macular degeneration includes therapies that focus on new molecular targets. Carl J. Danzig, MD, FASRS, discusses a tyrosine kinase inhibitor. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to view more education? Click here. Thu, 16 Jan 2025 22:20:00 -0000 full Evolve Medical Education, LLC The pipeline for the treatment of wet age-related macular degeneration includes therapies that focus on new molecular targets. Carl J. Danzig, MD, FASRS, discusses a tyrosine kinase inhibitor. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to view more education? Click here. The pipeline for the treatment of wet age-related macular degeneration includes therapies that focus on new molecular targets. Carl J. Danzig, MD, FASRS, discusses a tyrosine kinase inhibitor.


This activity is supported by an independent medical education grant from Ocular Therapeutix.


Click here to view the webinar event, which includes images from the talk.

Want to view more education? Click here.

]]> 763 no Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD https://evolvemeded.com/course/2413_Video3_Eichenbaum?utm_source=megaphone&utm_medium=ophthalmology_episode_description David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Thu, 15 Aug 2024 19:04:00 -0000 full Evolve Medical Education, LLC David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here. David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration.


This activity is supported by an independent medical education grant from Ocular Therapeutix.


Click here to view the webinar event, which includes images from the talk.


Want to register with Evolve Medical Education? Click here.

]]> 676 no Adapting to Progress: Gene Therapy for nAMD https://evolvemeded.com/course/2413_Video2_Chang?utm_source=megaphone&utm_medium=ophthalmology_episode_description Margaret A. Chang, MD, MS, will discuss gene therapies in the pipeline for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Thu, 15 Aug 2024 19:03:00 -0000 full Evolve Medical Education, LLC Margaret A. Chang, MD, MS, will discuss gene therapies in the pipeline for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Margaret A. Chang, MD, MS, will discuss gene therapies in the pipeline for the treatment of neovascular age-related macular degeneration.


This activity is supported by an independent medical education grant from Ocular Therapeutix.


Click here to view the webinar event, which includes images from the talk.


Want to register with Evolve Medical Education? Click here.

]]> 933 no Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion https://evolvemeded.com/course/2413_Video1_Dhoot_Khanani?utm_source=megaphone&utm_medium=ophthalmology_episode_description Drs. Dilsher Dhoot and Arshad M. Khanani explain the key aspects of the recently released FDA guidelines for clinical trial design in neovascular age-related macular degeneration and how these changes will influence the interpretation of clinical trial data and the subsequent integration of these therapies into clinical practice. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Tue, 25 Jun 2024 15:42:00 -0000 full Evolve Medical Education, LLC Drs. Dilsher Dhoot and Arshad M. Khanani explain the key aspects of the recently released FDA guidelines for clinical trial design in neovascular age-related macular degeneration and how these changes will influence the interpretation of clinical trial data and the subsequent integration of these therapies into clinical practice. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Drs. Dilsher Dhoot and Arshad M. Khanani explain the key aspects of the recently released FDA guidelines for clinical trial design in neovascular age-related macular degeneration and how these changes will influence the interpretation of clinical trial data and the subsequent integration of these therapies into clinical practice.


This activity is supported by an independent medical education grant from Ocular Therapeutix.


Click here to view the webinar event, which includes images from the talk.


Want to register with Evolve Medical Education? Click here.

]]> 1890 no Consensus Conversations: Neurotrophic Keratitis: Implementing Best Practices https://evolvemeded.com/course/2318_Video6?utm_source=megaphone&utm_medium=ophthalmology_episode_description Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 30 Apr 2024 00:10:00 -0000 full Evolve Medical Education, LLC Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.  


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1713 no Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents https://evolvemeded.com/course/2318_Video5?utm_source=megaphone&utm_medium=ophthalmology_episode_description Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 30 Apr 2024 00:10:00 -0000 full Evolve Medical Education, LLC Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.  


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 2030 no Consensus Conversations: Treating Stage 1 Neurotrophic Keratitis https://evolvemeded.com/course/2318_Video4?utm_source=megaphone&utm_medium=ophthalmology_episode_description Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 30 Apr 2024 00:09:00 -0000 full Evolve Medical Education, LLC Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.  


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1362 no Diabetic Macular Edema https://evolvemeded.com/course/2343_Video6_Adam_Vajzovic?utm_source=megaphone&utm_medium=ophthalmology_episode_description In this case-based discussion focused on diabetic macular edema, Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, highlight the use of more durable treatment options and how to incorporate these second-generation therapies into the armamentarium. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Fri, 08 Mar 2024 15:28:00 -0000 full Evolve Medical Education, LLC In this case-based discussion focused on diabetic macular edema, Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, highlight the use of more durable treatment options and how to incorporate these second-generation therapies into the armamentarium. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. In this case-based discussion focused on diabetic macular edema, Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, highlight the use of more durable treatment options and how to incorporate these second-generation therapies into the armamentarium.


This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1092 no Managing AMD: Integrating Newer Therapies https://evolvemeded.com/course/2343_Video5_Adam_Vajzovic?utm_source=megaphone&utm_medium=ophthalmology_episode_description Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, discuss two cases involving patients with neovascular age-related macular degeneration and the decision-making process used to determine the best treatment approaches. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Fri, 08 Mar 2024 15:27:00 -0000 full Evolve Medical Education, LLC Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, discuss two cases involving patients with neovascular age-related macular degeneration and the decision-making process used to determine the best treatment approaches. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, discuss two cases involving patients with neovascular age-related macular degeneration and the decision-making process used to determine the best treatment approaches.


This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1517 no KOL KNOCKOUT™: Cataract Edition | Aligning Patient Preferences and Ocular Characteristics for Optimal IOL Matchmaking - Round 3 Final Round https://www.evolvemeded.com/course/2330-round-3-enduring?utm_source=megaphone&utm_medium=episode_description Back by popular demand, this fun and exciting game show-style program features key opinion leaders (KOLs) as contestants! Hosted by Dr. Blake K. Williamson, this episode is full of learning and laughter! The winner of Round 2, Dr. Sumitra Khandelwal, joins two new KOLs, Drs. Kendall E. Donaldson & Vance Thompson, to battle it out in this final round! Who is the champion? Listen now to find out! This activity is supported by an independent educational grant from Alcon. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 28 Feb 2024 17:55:00 -0000 full Evolve Medical Education, LLC Back by popular demand, this fun and exciting game show-style program features key opinion leaders (KOLs) as contestants! Hosted by Dr. Blake K. Williamson, this episode is full of learning and laughter! The winner of Round 2, Dr. Sumitra Khandelwal, joins two new KOLs, Drs. Kendall E. Donaldson & Vance Thompson, to battle it out in this final round! Who is the champion? Listen now to find out! This activity is supported by an independent educational grant from Alcon. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Back by popular demand, this fun and exciting game show-style program features key opinion leaders (KOLs) as contestants!

Hosted by Dr. Blake K. Williamson, this episode is full of learning and laughter! The winner of Round 2, Dr. Sumitra Khandelwal, joins two new KOLs, Drs. Kendall E. Donaldson & Vance Thompson, to battle it out in this final round!

Who is the champion? Listen now to find out!


This activity is supported by an independent educational grant from Alcon.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 3497 no KOL KNOCKOUT™: Cataract Edition | Aligning Patient Preferences and Ocular Characteristics for Optimal IOL Matchmaking - Round 2 https://www.evolvemeded.com/course/2330-kol-knockout-round-2-enduring?utm_source=megaphone&utm_medium=episode_description This popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the second of three rounds features Sumitra Khandelwal, MD; R. Luke Rebenitsch, MD; and Bennett Walton, MD, MBA, as contestants. Dr. Williamson presents complex cataract surgery case studies and each KOL weighs in on their preferred treatment option. Find out who will advance to the final round! This activity is supported by an independent educational grant from Alcon. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 28 Feb 2024 17:54:00 -0000 full Evolve Medical Education, LLC This popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the second of three rounds features Sumitra Khandelwal, MD; R. Luke Rebenitsch, MD; and Bennett Walton, MD, MBA, as contestants. Dr. Williamson presents complex cataract surgery case studies and each KOL weighs in on their preferred treatment option. Find out who will advance to the final round! This activity is supported by an independent educational grant from Alcon. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. This popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the second of three rounds features Sumitra Khandelwal, MD; R. Luke Rebenitsch, MD; and Bennett Walton, MD, MBA, as contestants.

Dr. Williamson presents complex cataract surgery case studies and each KOL weighs in on their preferred treatment option. Find out who will advance to the final round!


This activity is supported by an independent educational grant from Alcon.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 4621 no KOL KNOCKOUT™: Cataract Edition | Aligning Patient Preferences and Ocular Characteristics for Optimal IOL Matchmaking - Round 1 https://www.evolvemeded.com/course/2330-kol-knockout-round-1-enduring?utm_source=megaphone&utm_medium=episode_description This popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the first of three rounds features Zaina Al-Mohtaseb, MD; Michael Greenwood, MD; and Bennett Walton, MD, MBA, as contestants. Dr. Williamson presents complex cataract surgery case studies and each KOL weighs in on their preferred treatment option. Find out who will advance to the next round! This activity is supported by an independent educational grant from Alcon. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 28 Feb 2024 17:53:00 -0000 full Evolve Medical Education, LLC This popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the first of three rounds features Zaina Al-Mohtaseb, MD; Michael Greenwood, MD; and Bennett Walton, MD, MBA, as contestants. Dr. Williamson presents complex cataract surgery case studies and each KOL weighs in on their preferred treatment option. Find out who will advance to the next round! This activity is supported by an independent educational grant from Alcon. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. This popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the first of three rounds features Zaina Al-Mohtaseb, MD; Michael Greenwood, MD; and Bennett Walton, MD, MBA, as contestants.

Dr. Williamson presents complex cataract surgery case studies and each KOL weighs in on their preferred treatment option. Find out who will advance to the next round!


This activity is supported by an independent educational grant from Alcon.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 4813 no Thyroid Eye Disease (TED) VideoBytes: From Graves to Gaze https://evolvemeded.com/course/2329_Microlearning-4?utm_source=megaphone&utm_medium=ophthalmology_episode_description In this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that recurred following orbital decompression surgery and presented with diplopia. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 22:08:00 -0000 full Evolve Medical Education, LLC In this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that recurred following orbital decompression surgery and presented with diplopia. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. In this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that recurred following orbital decompression surgery and presented with diplopia.


This activity is supported by an unrestricted educational grant from Horizon Therapeutics.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 955 no Thyroid Eye Disease (TED) VideoBytes: An Emphasis on Diagnosis https://evolvemeded.com/course/2329_Microlearning-3?utm_source=megaphone&utm_medium=ophthalmology_episode_description Join Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 22:07:00 -0000 full Evolve Medical Education, LLC Join Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Join Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED.


This activity is supported by an unrestricted educational grant from Horizon Therapeutics.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 947 no Thyroid Eye Disease (TED) VideoBytes: Managing Chronic TED https://evolvemeded.com/course/2329_Microlearning-2?utm_source=megaphone&utm_medium=ophthalmology_episode_description In this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a case study highlighting the successful use of biologic therapy in managing chronic TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 22:06:00 -0000 full Evolve Medical Education, LLC In this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a case study highlighting the successful use of biologic therapy in managing chronic TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. In this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a case study highlighting the successful use of biologic therapy in managing chronic TED.


This activity is supported by an unrestricted educational grant from Horizon Therapeutics.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 947 no Thyroid Eye Disease (TED) VideoBytes: Delayed Diagnosis of Advanced TED https://evolvemeded.com/course/2329_Microlearning-1?utm_source=megaphone&utm_medium=ophthalmology_episode_description Kim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six other eye care providers, and was eventually successfully treated with teprotumumab. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 22:05:00 -0000 full Evolve Medical Education, LLC Kim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six other eye care providers, and was eventually successfully treated with teprotumumab. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six other eye care providers, and was eventually successfully treated with teprotumumab.


This activity is supported by an unrestricted educational grant from Horizon Therapeutics.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 935 no Optimizing Management Strategies in Challenging Cases https://evolvemeded.com/course/2343_Video4_Danzig_Kitchens?utm_source=megaphone&utm_medium=ophthalmology_episode_description In this episode, Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, one involving a 15-year-old who presents with neovascularization and an elderly patient with an extensive history of treatment who was switched to a second-generation therapy. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 16:43:00 -0000 full Evolve Medical Education, LLC In this episode, Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, one involving a 15-year-old who presents with neovascularization and an elderly patient with an extensive history of treatment who was switched to a second-generation therapy. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. In this episode, Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, one involving a 15-year-old who presents with neovascularization and an elderly patient with an extensive history of treatment who was switched to a second-generation therapy.


This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1215 no DME Treatment Strategies With Longer Duration Therapies https://evolvemeded.com/course/2343_Video3_Danzig_Kitchens?utm_source=megaphone&utm_medium=ophthalmology_episode_description Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, including a treatment-naïve patient with proliferative diabetic retinopathy and diabetic macular edema and a patient with a long history of anti-VEGF injections who was switched to aflibercept 8 mg. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 16:41:00 -0000 full Evolve Medical Education, LLC Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, including a treatment-naïve patient with proliferative diabetic retinopathy and diabetic macular edema and a patient with a long history of anti-VEGF injections who was switched to aflibercept 8 mg. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, including a treatment-naïve patient with proliferative diabetic retinopathy and diabetic macular edema and a patient with a long history of anti-VEGF injections who was switched to aflibercept 8 mg.


This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1125 no Next-Generation Anti-VEGFs: Finding Durable Solutions to Retinal Diseases https://evolvemeded.com/course/2343_Video2_Kim_Yee?utm_source=megaphone&utm_medium=ophthalmology_episode_description David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss second-generation retinal disease therapies and how they may offer benefits for certain patients. These retina specialists also share their experience with the newer agents through challenging real-world case studies. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 30 Jan 2024 18:04:00 -0000 full Evolve Medical Education, LLC David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss second-generation retinal disease therapies and how they may offer benefits for certain patients. These retina specialists also share their experience with the newer agents through challenging real-world case studies. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss second-generation retinal disease therapies and how they may offer benefits for certain patients. These retina specialists also share their experience with the newer agents through challenging real-world case studies.


This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1545 no Considerations for More Durable Agents in Treatment of Neovascular Age-Related Macular Degeneration: Data Review and Case Studies https://evolvemeded.com/course/2343_Video1_Kim_Yee?utm_source=megaphone&utm_medium=ophthalmology_episode_description David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss clinical trial data of newer, longer duration retinal disease therapies and share real-world case studies utilizing these new agents for their patients. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 30 Jan 2024 18:01:00 -0000 full Evolve Medical Education, LLC David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss clinical trial data of newer, longer duration retinal disease therapies and share real-world case studies utilizing these new agents for their patients. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss clinical trial data of newer, longer duration retinal disease therapies and share real-world case studies utilizing these new agents for their patients.


This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1532 no Consensus Conversations: Neurotrophic Keratitis Classification https://evolvemeded.com/course/2318_Video3?utm_source=megaphone&utm_medium=ophthalmology_episode_description Classification of neurotrophic keratitis is moving away from the Mackie system. Drs. Nichols and Whitley highlight the Neurotrophic Keratitis Study Group classification system and explain the clinical features of each stage. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 27 Dec 2023 20:10:00 -0000 full Evolve Medical Education, LLC Classification of neurotrophic keratitis is moving away from the Mackie system. Drs. Nichols and Whitley highlight the Neurotrophic Keratitis Study Group classification system and explain the clinical features of each stage. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Classification of neurotrophic keratitis is moving away from the Mackie system. Drs. Nichols and Whitley highlight the Neurotrophic Keratitis Study Group classification system and explain the clinical features of each stage.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1030 no Consensus Conversations: Testing Corneal Sensitivity https://evolvemeded.com/course/2318_Video2?utm_source=megaphone&utm_medium=ophthalmology_episode_description Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, explain why it’s important to perform corneal sensitivity testing on patients suspected of having neurotrophic keratitis and provide tips on best practices. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 27 Dec 2023 20:08:00 -0000 full Evolve Medical Education, LLC Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, explain why it’s important to perform corneal sensitivity testing on patients suspected of having neurotrophic keratitis and provide tips on best practices. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, explain why it’s important to perform corneal sensitivity testing on patients suspected of having neurotrophic keratitis and provide tips on best practices.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1031 no Consensus Conversations: Neurotrophic Keratitis Prevalence https://evolvemeded.com/course/2318_Video1?utm_source=megaphone&utm_medium=ophthalmology_episode_description Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, present two cases and discuss why neurotrophic keratitis is difficult to diagnose and more prevalent than previously thought. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 27 Dec 2023 20:07:00 -0000 full Evolve Medical Education, LLC Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, present two cases and discuss why neurotrophic keratitis is difficult to diagnose and more prevalent than previously thought. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, present two cases and discuss why neurotrophic keratitis is difficult to diagnose and more prevalent than previously thought.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 994 no Harnessing DED Data: Emerging Therapies, Pipeline, and Cases https://evolvemeded.com/course/2331_Web1_Enduring?utm_source=megaphone&utm_medium=ophthalmology_episode_description Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies as well as the pipeline. Drs. Periman and Brujic also present cases. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Mon, 27 Nov 2023 23:00:00 -0000 full Evolve Medical Education, LLC Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies as well as the pipeline. Drs. Periman and Brujic also present cases. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies as well as the pipeline. Drs. Periman and Brujic also present cases. This content was captured during a live-virtual symposium.


This activity is supported by an unrestricted educational grant from Oyster Point.


Click here to view the on-demand webinar, which includes images from the talk.


Want to register with Evolve Medical Education? Click here. 

]]> 1130 no Harnessing DED Data: New and Emerging Therapies https://evolvemeded.com/course/2331_Web1_Enduring?utm_source=megaphone&utm_medium=ophthalmology_episode_description Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Mon, 27 Nov 2023 22:59:00 -0000 full Evolve Medical Education, LLC Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies. This content was captured during a live-virtual symposium.


This activity is supported by an unrestricted educational grant from Oyster Point.


Click here to view the on-demand webinar, which includes images from the talk.


Want to register with Evolve Medical Education? Click here. 

]]> 1169 no Harnessing DED Data: Comparison Studies https://evolvemeded.com/course/2331_Web1_Enduring?utm_source=megaphone&utm_medium=ophthalmology_episode_description Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Steen discusses recent comparison studies. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Mon, 27 Nov 2023 22:59:00 -0000 full Evolve Medical Education, LLC Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Steen discusses recent comparison studies. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Steen discusses recent comparison studies. This content was captured during a live-virtual symposium. Polling took place during the symposium.


This activity is supported by an unrestricted educational grant from Oyster Point.


Click here to view the on-demand webinar, which includes images from the talk.


Want to register with Evolve Medical Education? Click here. 

]]> 1143 no Harnessing DED Data: Prevalence, Risk Factors, and Diagnostic Tools https://evolvemeded.com/course/2331_Web1_Enduring?utm_source=megaphone&utm_medium=ophthalmology_episode_description Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Brujic highlights dry eye disease’s prevalence, risk factors, and diagnostic tools. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Mon, 27 Nov 2023 22:58:00 -0000 full Evolve Medical Education, LLC Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Brujic highlights dry eye disease’s prevalence, risk factors, and diagnostic tools. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Brujic highlights dry eye disease’s prevalence, risk factors, and diagnostic tools. This content was captured during a live-virtual symposium. Polling took place during the symposium.


This activity is supported by an unrestricted educational grant from Oyster Point.


Click here to view the on-demand webinar, which includes images from the talk.


Want to register with Evolve Medical Education? Click here. 

]]> 894 no Case: Physician With Intermittent Blurring https://evolvemeded.com/course/2313_Video4_Epitropoulos?utm_source=megaphone&utm_medium=episode_description Alice T. Epitropoulos, MD, FACS, discusses a case of meibomian gland dysfunction in a 66-year-old surgeon presenting for cataract evaluation. This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view Dr. Epitropoulos' webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Sat, 16 Sep 2023 09:25:00 -0000 full Evolve Medical Education, LLC Alice T. Epitropoulos, MD, FACS, discusses a case of meibomian gland dysfunction in a 66-year-old surgeon presenting for cataract evaluation. This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view Dr. Epitropoulos' webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Alice T. Epitropoulos, MD, FACS, discusses a case of meibomian gland dysfunction in a 66-year-old surgeon presenting for cataract evaluation.


This activity is supported by an unrestricted educational grant from Bausch + Lomb.


Click here to view Dr. Epitropoulos' webinar event, which includes images from the talk.


Want to register with Evolve Medical Education? Click here. 

]]> 657 no The Future of MGD Treatment https://evolvemeded.com/course/2313_Video3_Sheppard?utm_source=megaphone&utm_medium=episode_description John D. Sheppard, MD, MMSc, FACS, speaks about the future of pharmacological therapy for dry eye disease associated with meibomian gland dysfunction. This program was recorded prior to the approval of perfluorohexyloctane ophthalmic solution (formerly known as NOV03). This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view Dr. Sheppard's webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Fri, 15 Sep 2023 09:25:00 -0000 full Evolve Medical Education, LLC John D. Sheppard, MD, MMSc, FACS, speaks about the future of pharmacological therapy for dry eye disease associated with meibomian gland dysfunction. This program was recorded prior to the approval of perfluorohexyloctane ophthalmic solution (formerly known as NOV03). This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view Dr. Sheppard's webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  John D. Sheppard, MD, MMSc, FACS, speaks about the future of pharmacological therapy for dry eye disease associated with meibomian gland dysfunction. This program was recorded prior to the approval of perfluorohexyloctane ophthalmic solution (formerly known as NOV03).


This activity is supported by an unrestricted educational grant from Bausch + Lomb.


Click here to view Dr. Sheppard's webinar event, which includes images from the talk.


Want to register with Evolve Medical Education? Click here. 

]]> 880 no Treatments for MGD https://evolvemeded.com/course/2313_Video2_Epitropoulos?utm_source=megaphone&utm_medium=episode_description Alice T. Epitropoulos, MD, FACS, highlights the treatments for dry eye disease secondary to meibomian gland dysfunction. This activity is supported by an unrestricted educational grant from Bausch + Lomb.  Click here to view Dr. Epitropoulos' webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Thu, 14 Sep 2023 09:25:00 -0000 full Evolve Medical Education, LLC Alice T. Epitropoulos, MD, FACS, highlights the treatments for dry eye disease secondary to meibomian gland dysfunction. This activity is supported by an unrestricted educational grant from Bausch + Lomb.  Click here to view Dr. Epitropoulos' webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Alice T. Epitropoulos, MD, FACS, highlights the treatments for dry eye disease secondary to meibomian gland dysfunction.


This activity is supported by an unrestricted educational grant from Bausch + Lomb. 


Click here to view Dr. Epitropoulos' webinar event, which includes images from the talk.


Want to register with Evolve Medical Education? Click here. 

]]> 813 no Diagnosing DED: Signs, Symptoms, and Testing https://evolvemeded.com/course/2313_Video1_Greenwood?utm_source=megaphone&utm_medium=episode_description Michael Greenwood, MD, examines the tools available to accurately diagnose meibomian gland dysfunction-related dry eye disease. This activity is supported by an unrestricted educational grant from Bausch + Lomb.  Click here to view Dr. Greenwood’s webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Wed, 13 Sep 2023 09:25:00 -0000 full Evolve Medical Education, LLC Michael Greenwood, MD, examines the tools available to accurately diagnose meibomian gland dysfunction-related dry eye disease. This activity is supported by an unrestricted educational grant from Bausch + Lomb.  Click here to view Dr. Greenwood’s webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Michael Greenwood, MD, examines the tools available to accurately diagnose meibomian gland dysfunction-related dry eye disease.


This activity is supported by an unrestricted educational grant from Bausch + Lomb. 


Click here to view Dr. Greenwood’s webinar event, which includes images from the talk.


Want to register with Evolve Medical Education? Click here. 

]]> 1051 no DED Origin Story: Understanding the Role of MGD https://evolvemeded.com/course/2313_ASCRS_2023_Enduring?utm_source=megaphone&utm_medium=episode_description This episode features Program Chair Alice T. Epitropoulos, MD, FACS, along with Michael Greenwood, MD, and John D. Sheppard, MD, MMSc, discussing how meibomian gland dysfunction interacts with dry eye disease and the latest data on new and emerging treatments. This content was captured during a live symposium. This program was recorded prior to the approval of perfluorohexyloctane ophthalmic solution (formerly known as NOV03).   This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view the on-demand webinar, which includes images from the talk.   Want to register with Evolve Medical Education? Click here.  Tue, 12 Sep 2023 20:25:00 -0000 full Evolve Medical Education, LLC This episode features Program Chair Alice T. Epitropoulos, MD, FACS, along with Michael Greenwood, MD, and John D. Sheppard, MD, MMSc, discussing how meibomian gland dysfunction interacts with dry eye disease and the latest data on new and emerging treatments. This content was captured during a live symposium. This program was recorded prior to the approval of perfluorohexyloctane ophthalmic solution (formerly known as NOV03).   This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view the on-demand webinar, which includes images from the talk.   Want to register with Evolve Medical Education? Click here.  This episode features Program Chair Alice T. Epitropoulos, MD, FACS, along with Michael Greenwood, MD, and John D. Sheppard, MD, MMSc, discussing how meibomian gland dysfunction interacts with dry eye disease and the latest data on new and emerging treatments. This content was captured during a live symposium. This program was recorded prior to the approval of perfluorohexyloctane ophthalmic solution (formerly known as NOV03).

 

This activity is supported by an unrestricted educational grant from Bausch + Lomb.


Click here to view the on-demand webinar, which includes images from the talk.  


Want to register with Evolve Medical Education? Click here. 

]]> 3258 no